Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-23-020711
Filing Date
2023-06-02
Accepted
2023-06-02 18:11:25
Documents
3
Period of Report
2023-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1685743873.html 4  
1 FORM 4 wk-form4_1685743873.xml 4 3494
2 EX-24 reitanpoaform20220627.htm EX-24 4349
3 GRAPHIC reitanpoaform20220627001.jpg GRAPHIC 260834
  Complete submission text file 0001628280-23-020711.txt   368518
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address
Reitan Colleen F (Reporting) CIK: 0001740730 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 23990560